Jefferies has reiterated its “buy” rating forCordiant Digital Infrastructure Ltd (LSE:CORD), citing confidence in the growth potential of its core assets, Emitel and CRA.
Analysts pointed to the fund’s ability to generate earnings growth through reinvestment of cash flows and favourable shifts in revenue composition, which are expected to contribute to NAV growth over the coming year.
Shares of Quadrise PLC (AIM:QED) rose 18% in the first hour of trading after the company announced a partnership with Finland’s Auramarine to advance greener fuel technologies for the marine industry.
The collaboration will combine Quadrise’s cleaner fuels, MSAR and bioMSAR, with Auramarine’s expertise in fuel systems to help ships transition to lower-emission solutions.
Quadrise PLC (AIM:QED), the cleaner energy specialist, has partnered with Finland's Auramarine to develop and promote greener fuel technologies for the marine industry.
The collaboration aims to improve efficiency and reduce emissions in energy-intensive sectors, particularly shipping.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) marked a 'significant milestone' after it applied for regulatory approval of its new grass allergy immunotherapy.
The submission, made to Germany’s Paul Ehrlich Institut (PEI), includes evidence from a phase III clinical trial showing significant symptom reduction during peak pollen season.